MUKKA — Mukka Proteins Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹14.54bn
- IN₹17.37bn
- IN₹13.80bn
- 23
- 43
- 59
- 33
Annual cashflow statement for Mukka Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 197 | 155 | 360 | 659 | 875 |
| Depreciation | |||||
| Non-Cash Items | 16.2 | 12.2 | 33.5 | 69.8 | 95.1 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -511 | -191 | -431 | -1,392 | -2,597 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -251 | 59.5 | 48.1 | -544 | -1,504 |
| Capital Expenditures | -364 | -107 | -65.1 | -82.2 | -156 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 84.2 | -29.4 | -57.7 | 29.6 | -320 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -280 | -136 | -123 | -52.6 | -476 |
| Financing Cash Flow Items | -50.2 | -73.3 | -74.3 | -113 | -186 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 538 | 93.2 | 159 | 747 | 2,659 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.41 | 16.6 | 83.8 | 150 | 679 |